Click on image to view larger version.

Figure 1 Change in ejection fraction in the placebo and atorvastatin groups during the 12-month study follow up. *p = 0.01 for the difference in ejection fraction between baseline and 6 or 12 months within the atorvastatin group; p = 0.04 for the difference in ejection fraction between baseline and 12 months within the placebo group; p = 0.004 for the difference in ejection fraction at 12 months between the placebo and the atorvastatin groups.